Skip to main content
Back to feed
HealthSingle-sourceLow
2.1

Boehringer Ingelheim reports 15.8 billion euro revenue driven by Jardiance sales

Boehringer Ingelheim's total revenue reached 15.8 billion euros, with the diabetes drug Jardiance contributing 5.7 billion euros. While Jardiance is currently marketed in several regions, it awaits regulatory approval in the European market.

Die Presse3 days agoDECredibility 26%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.3

Intelligence Tags

#pharmaceuticals#revenue#diabetes#boehringer ingelheim#jardiance

Entities

country
Source

Related signals

8 found